Medical Director Articles

The term "article" is used to describe any bulletin article, web site article, educational handout or any other non-LCD document intended for public release that contains coverage/coding statements or medical review related billing or claims considerations.

Articles address local coverage, coding or medical review related billing and claims considerations, and may include any newly developed educational materials, coding instructions or clarification of existing medical review related billing or claims policy.

The article listing will continue to expand as additions are made.

Last Updated Jan 30 , 2024
Articles Source Posted
Self-Administered Drug Exclusion List (A53032) - R39 - Effective September 11, 2024 Sep 26, 2024
Multijurisdictional Contractor Advisory Committee (CAC) Superficial Radiation Therapy (SRT) For The Treatment Of Nonmelanoma Skin Cancers (NMSC) - Bibliography Sep 24, 2024
Billing and Coding: MolDX: BCR-ABL (A55595)- R5 - Effective September 19, 2024 Sep 19, 2024
Urine Drug Testing - Published for Review and Comments Sep 19, 2024
Noridian Molecular Diagnostic (MolDX) Updates from Provider Suggestion Sep 17, 2024
Multi-Jurisdictional CAC Meeting Announcement - Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) - October 17, 2024, 2 - 4 p.m. CT Sep 13, 2024
Multijurisdictional Contractor Advisory Committee (CAC) Superficial Radiation Therapy (SRT) for the Treatment of Nonmelanoma Skin Cancers (NMSC) - Agenda Sep 13, 2024
Multijurisdictional Contractor Advisory Committee (CAC) Superficial Radiation Therapy (SRT) For The Treatment Of Nonmelanoma Skin Cancers (NMSC) - Key Questions Sep 13, 2024
Billing and Coding: MolDX: Blood Product Molecular Antigen Typing (A57124) - R5 - Effective October 1, 2024 Sep 12, 2024
Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (A57421) - R11 - Effective October 1, 2024 Sep 12, 2024